Cardiovascular risk prediction with cardio-ankle vascular index in the malaysian cohort study

Abdullah, Noraidatulakma; Blin, Joan Anak; Kamalul Arifin, Azwa Shawani; Abd Jalal, Nazihah; Ismail, Norliza; Mohd Yusof, Nurul Ain; Abdullah, Mohd Shaharom; Husin, Nurul Faeizah; Dauni, Andri; Kamaruddin, Mohd Arman; Mohammed Nawi, Azmawati; Ahmad, Norfazilah; Hassan, Mohd Rohaizat; Jamal, Rahman

doi:10.1016/j.cpcardiol.2023.102192

Cited by 4 publications

(1 citation statement)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the measurement of PWV is notably susceptible to blood pressure variations, posing a significant limitation. To overcome it, another formula of PWV calculation, termed cardio-ankle vascular index (CAVI) has been proposed [9]. Previous studies have demonstrated the discriminatory power of CAVI to stratify the CVD risk in patients without previous overt CVDs [10].…”

Section: Introductionmentioning

confidence: 99%

Altered Arterial Stiffness, Ventricular–Arterial Coupling and Troponin Levels in Patients with Systemic Lupus Erythematosus

Kadoglou,

Dimopoulou,

Gkougkoudi

et al. 2024

Medicina

View full text Add to dashboard Cite

Introduction: Systemic Lupus Erythematosus (SLE) is an autoimmune disease associated with an increased risk of cardiovascular diseases (CVDs), leading to elevated mortality rates among patients. We aimed to evaluate the levels of cardio–ankle vascular index (CAVI), global longitudinal strain (GLS), ventricular–arterial coupling (VAC), and high-sensitivity cardiac troponin I (hsTnI) in SLE patients and to explore their relationship with clinical parameters. Methods: This cross-sectional study enrolled 82 SLE patients without evident cardiac or kidney impairment and 41 age- and sex-matched healthy controls. We comparatively evaluated CAVI, GLS, VAC, and hsTnI between SLE patients and controls, and we assessed their association among SLE patients with disease activity based on the SELENA–SLEDAI Activity Index. Multivariate regression analysis was performed to identify independent predictors of CAVI and hsTnI within the SLE cohort. Results: In comparison to healthy controls, SLE patients presented with significantly higher CAVI, GLS, and hsTnI levels, while VAC was significantly reduced (p < 0.001). Furthermore, SLE patients with active disease (SELENA–SLEDAI ≥ 4) exhibited higher levels of CAVI and troponin than those with inactive disease (p < 0.001). SLEDAI was an independent predictor of CAVI, while VAC and SLEDAI were independent determinants of hsTnI in the SLE cohort. Conclusions: SLE patients displayed abnormal levels of CAVI, VAC, GLS, and troponin compared to healthy individuals. Our findings implicate the potential of those CV novel CVD risk factors to refine screening and therapeutic strategies for this specific population.

show abstract

Section: Introductionmentioning

confidence: 99%